SE7608453L - Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner - Google Patents

Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner

Info

Publication number
SE7608453L
SE7608453L SE7608453A SE7608453A SE7608453L SE 7608453 L SE7608453 L SE 7608453L SE 7608453 A SE7608453 A SE 7608453A SE 7608453 A SE7608453 A SE 7608453A SE 7608453 L SE7608453 L SE 7608453L
Authority
SE
Sweden
Prior art keywords
tetrahydroisochinolines
procedure
preparation
Prior art date
Application number
SE7608453A
Other languages
English (en)
Other versions
SE423233B (sv
Inventor
T Kishimoto
I Ueda
M Kato
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of SE7608453L publication Critical patent/SE7608453L/sv
Publication of SE423233B publication Critical patent/SE423233B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
SE7608453A 1975-07-28 1976-07-26 Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner SE423233B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31570/75A GB1553230A (en) 1975-07-28 1975-07-28 1 - aminomethyl - 6,7-dihydroxy - 1,2,3,4-tetrahydroisoquinolines and the preparation thereof

Publications (2)

Publication Number Publication Date
SE7608453L true SE7608453L (sv) 1977-01-29
SE423233B SE423233B (sv) 1982-04-26

Family

ID=10325102

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608453A SE423233B (sv) 1975-07-28 1976-07-26 Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner

Country Status (19)

Country Link
US (1) US4096263A (sv)
JP (1) JPS5217477A (sv)
AR (1) AR212174A1 (sv)
AT (1) AT358588B (sv)
AU (1) AU506715B2 (sv)
BE (1) BE844472A (sv)
CA (1) CA1068276A (sv)
CH (1) CH623310A5 (sv)
DE (1) DE2633692A1 (sv)
DK (1) DK143750C (sv)
ES (1) ES450206A1 (sv)
FR (1) FR2319357A1 (sv)
GB (1) GB1553230A (sv)
IE (1) IE43502B1 (sv)
IT (1) IT1063405B (sv)
MX (1) MX3999E (sv)
NL (1) NL7608319A (sv)
SE (1) SE423233B (sv)
ZA (1) ZA764508B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5734275B2 (sv) * 1973-07-30 1982-07-22
US4456757A (en) * 1981-03-20 1984-06-26 Asahi Kasei Kogyo Kabushiki Kaisha Isoquinolinesulfonyl derivatives and process for the preparation thereof
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
JP4889463B2 (ja) * 2006-12-07 2012-03-07 株式会社椿本バルクシステム チェーンコンベヤ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3389140A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-arylaminoethyl-2-methyl-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinolines
US3963725A (en) * 1973-07-20 1976-06-15 Fujisawa Pharmaceutical Co., Ltd. 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof
JPS5734275B2 (sv) * 1973-07-30 1982-07-22
US3994891A (en) * 1974-12-20 1976-11-30 Armour Pharmaceutical Company Tetrahydroisoquinoline compounds

Also Published As

Publication number Publication date
BE844472A (fr) 1977-01-24
ATA552076A (de) 1980-02-15
GB1553230A (en) 1979-09-26
JPS5217477A (en) 1977-02-09
AR212174A1 (es) 1978-05-31
MX3999E (es) 1981-10-28
NL7608319A (nl) 1977-02-01
FR2319357B1 (sv) 1978-11-17
FR2319357A1 (fr) 1977-02-25
SE423233B (sv) 1982-04-26
US4096263A (en) 1978-06-20
CA1068276A (en) 1979-12-18
DK143750C (da) 1982-03-29
AT358588B (de) 1980-09-25
AU506715B2 (en) 1980-01-24
AU1629076A (en) 1978-02-02
DK336676A (da) 1977-01-29
CH623310A5 (sv) 1981-05-29
IE43502L (en) 1977-01-28
DK143750B (da) 1981-10-05
DE2633692A1 (de) 1977-02-17
IT1063405B (it) 1985-02-11
ES450206A1 (es) 1977-11-16
ZA764508B (en) 1977-07-27
IE43502B1 (en) 1981-03-11

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE7603791L (sv) Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
RO75777A (ro) Procedeu pentru prepararea unor 1,2-benzizotiazolin-3-one
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
SE419983B (sv) Forfarande for framstellning av finkornig, fast cyanurklorid
SE409864B (sv) Forfarande for framstellning av 4-imino-1,3-diazabicyklo(3.1.0)hexan-2-on
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE7804878L (sv) Forfarande for framstellning av 1,2-dikloretan
SE7601605L (sv) Forfarande for framstellning av 1 alfa,25-dihydroxi-cholkalciferol
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE426067B (sv) Forfarande for framstellning av 9-hydroxi-7,8,9,10-tetrahydro-6h-dibenso (b,d) pyraner och -pyranoner
SE420999B (sv) Framstellning av 2,4-diamino-5-bensylpyrimidiner
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
SE7600321L (sv) Forfarande for framstellning av 6,11-dihydro-11-oxodibens(b,e)oxepinalkansyror
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
AR210905A1 (es) Procedimiento de preparacion de 2,4-diamino-5-bencil-pirimidinas
SE7605427L (sv) Forfarande for framstellning av klorcyan